CRISPR/Cas gene editing and delivery systems for cancer therapy
Authors:
- 26 January 2024
- journal article
- review article
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 16 (1) , e1938
Abstract
CRISPR/Cas systems stand out because of simplicity, efficiency, and other superiorities, thus becoming attractive and brilliant gene‐editing tools in biomedical field including cancer therapy. CRISPR/Cas systems bring promises for cancer therapy through manipulating and engineering on tumor cells or immune cells. However, there have been concerns about how to overcome the numerous physiological barriers and deliver CRISPR components to target cells efficiently and accurately. In this review, we introduced the mechanisms of CRISPR/Cas systems, summarized the current delivery strategies of CRISPR/Cas systems by physical methods, viral vectors, and nonviral vectors, and presented the current application of CRISPR/Cas systems in cancer clinical treatment. Furthermore, we discussed prospects related to delivery approaches of CRISPR/Cas systems.This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic DiseaseKeywords
Funding Information
- Key Research and Development Program of Sichuan Province (2023YFS0153)
- National Natural Science Foundation of China (82172094)
- Science Fund for Distinguished Young Scholars of Sichuan Province (2021JDJQ0037)
This publication has 188 references indexed in Scilit:
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Physical Non-Viral Gene Delivery Methods for Tissue EngineeringAnnals of Biomedical Engineering, 2012
- Endosomal escape pathways for delivery of biologicalsJournal of Controlled Release, 2011
- Uniformity of Drug Payload and Its Effect on Stability of Solid Lipid Nanoparticles Containing an Ester ProdrugACS Nano, 2010
- Charge‐Conversion Ternary Polyplex with Endosome Disruption Moiety: A Technique for Efficient and Safe Gene DeliveryAngewandte Chemie International Edition, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Cyclic stretch-induced reorganization of the cytoskeleton and its role in enhanced gene transferGene Therapy, 2006
- The Innate Immune Response to Adenovirus VectorsHuman Gene Therapy, 2004
- Metal-organic frameworksChemical Society Reviews, 2003
- Lentiviruses in gene therapy clinical researchGene Therapy, 2002